rfhg_50805.1

Basic information about the TSS

---

TSS ID: rfhg_50805.1 Species: human Chr: chr3		Start: 139383378 End: 139383388 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: JF432305:-48 CU674160:-48 GeneID: 9276 HGNC/MGI_ID: HGNC:2232 UniProt_ID: Nearer transcript ids and distances:

Gene_name: COPI coat complex subunit beta 2 Gene_symbol: COPB2 Gene_synonyms: beta'-COP betaprime-COP Gene_source: HGNC:2232

TATA-Box annotation

---

Distance to TSS:	6264
Nearest PromoterID:	NM_004766
Entrez ID:	9276
Nearest Unigene:	Hs.681616
Nearest Refseq:	NM_004766
Nearest Ensembl:	ENSG00000184432
Gene Name:	COPI coat complex subunit beta 2
Gene Alias:	MCPH19|beta'-COP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.363636
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@COPB2 p2@COPB2 p3@COPB2
Sample		p1@COPB2	p2@COPB2	p3@COPB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	33.31	3.31	3.12
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	41.88	3.44	4.25
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.35	2.51	2.70
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	30.56	3.53	4.57
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	32.40	0.90	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	32.75	1.55	2.13
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	50.11	5.23	3.92
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	51.83	6.06	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	40.18	3.21	4.70
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	46.37	5.22	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	43.25	6.47	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	34.15	4.47	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.27	1.77	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	28.87	2.71	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.39	1.54	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	27.66	1.76	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	27.08	1.31	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.62	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.06	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	22.87	1.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.01	1.87	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	30.73	2.42	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.38	2.07	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	29.36	1.70	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	28.12	2.58	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	27.22	2.22	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.63	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	34.42	2.12	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.68	1.62	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	33.84	3.80	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.40	1.88	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.88	1.76	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.21	4.85	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	44.53	2.80	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.80	3.18	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.02	1.15	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	27.18	2.45	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	30.22	1.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	38.89	3.51	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	28.81	3.84	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.11	2.35	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	36.89	2.93	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	29.53	3.80	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.64	2.45	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	29.51	3.61	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	26.75	2.56	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.07	2.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.61	3.58	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.43	2.39	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	32.96	2.02	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.25	3.48	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	39.80	2.67	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	685.62	125.93	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	36.20	2.48	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	42.42	3.98	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	216.45	25.17	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	66.59	5.05	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	45.05	4.21	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.29	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	65.38	5.97	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	34.55	4.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	39.82	3.36	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	57.32	8.76	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	39.75	2.72	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.52	3.90	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.37	3.55	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	824.36	96.98	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	623.90	102.67	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	43.39	1.95	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	30.25	0.99	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	45.03	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	45.04	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	51.35	3.40	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	48.00	1.22	0.61
Adipocyte - breast, donor1	11376-118A8	160.44	18.85	6.81
Adipocyte - breast, donor2	11327-117E4	83.74	7.38	5.29
Adipocyte - omental, donor1	11473-119C6	159.67	20.87	7.38
Adipocyte - omental, donor2	11474-119C7	87.46	9.72	4.48
Adipocyte - omental, donor3	11475-119C8	59.28	7.70	2.34
Adipocyte - perirenal, donor1	11476-119C9	78.47	9.57	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	31.89	6.60	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	92.13	8.13	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	43.62	5.04	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	87.62	14.86	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	64.34	4.89	2.32
Adipocyte differentiation, day04, donor3	13025-139E1	76.10	4.18	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	47.02	3.53	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	93.22	10.05	2.65
Adipocyte differentiation, day08, donor2	13023-139D8	56.16	4.84	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	57.58	4.27	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	53.42	3.90	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	50.74	3.74	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	59.28	4.27	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	53.67	5.24	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	38.67	3.96	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	18.78	1.10	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	2.87	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.59	0.90	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.18	0.82	0.41
Anulus Pulposus Cell, donor1	11248-116E6	143.38	13.16	4.12
Anulus Pulposus Cell, donor2	11463-119B5	50.45	4.16	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	85.37	6.29	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	79.88	9.99	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	66.35	12.84	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	79.21	8.07	5.68
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	86.00	5.06	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	58.09	5.28	6.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	65.95	5.20	5.20
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	95.15	7.28	3.88
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	73.05	4.75	9.50
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	82.11	7.91	4.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	82.00	2.90	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	55.17	6.27	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	112.19	11.20	12.03
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	53.23	4.09	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	79.77	8.14	6.18
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	82.51	5.36	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	61.59	6.80	3.59
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	68.69	8.29	5.61
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	45.85	2.93	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	68.17	8.62	5.97
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	60.04	7.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	7.08	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	69.30	9.61	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	8.39	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	80.10	5.34	7.77
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	75.89	6.45	6.07
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	64.20	7.27	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	86.65	6.84	5.70
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	65.63	8.12	4.49
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	53.68	6.97	5.68
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	62.87	3.28	3.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	64.63	6.43	4.18
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	63.50	9.99	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	69.02	3.51	4.68
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	67.74	9.03	5.72
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	66.53	5.94	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	84.42	6.61	4.58
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	82.77	7.39	3.31
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	54.64	6.35	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	63.00	9.06	3.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	66.68	6.14	4.66
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	55.97	6.38	4.06
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	58.57	5.67	8.50
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	68.49	6.61	4.75
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	50.96	4.63	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	78.17	8.45	12.68
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	63.25	6.43	5.36
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	61.97	7.82	6.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	62.69	8.75	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	77.93	6.67	8.05
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	58.66	10.20	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	79.57	9.15	7.37
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	72.25	6.40	7.23
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	61.51	6.43	6.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	104.68	9.08	9.56
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	75.39	4.88	3.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	61.03	6.10	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	79.76	8.86	4.98
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	73.61	8.21	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	59.24	6.54	3.27
Astrocyte - cerebellum, donor1	11500-119F6	25.18	2.33	1.11
Astrocyte - cerebellum, donor2	11580-120F5	10.95	0.68	0.17
Astrocyte - cerebellum, donor3	11661-122F5	8.39	0.63	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	111.55	12.55	3.49
Astrocyte - cerebral cortex, donor2	11316-117D2	57.27	7.60	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	89.35	8.20	3.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	105.74	5.28	2.87
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	108.87	9.02	3.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	120.06	7.62	2.50
Basophils, donor1	12241-129G9	10.46	0.52	1.57
Basophils, donor2	12242-129H1	18.04	1.08	1.08
Basophils, donor3	12243-129H2	11.76	0.88	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	12.72	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.71	2.51	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	15.60	1.25	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	22.57	3.22	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	52.90	3.96	1.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	69.87	2.89	1.85
Burkitt's lymphoma cell line:RAJI	10476-106I8	103.41	7.45	2.56
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	57.24	2.88	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	20.29	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	11.69	0.93	1.11
CD14+ Monocytes, donor3	11381-118B4	22.83	1.54	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	112.65	5.09	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	89.46	8.34	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	95.33	6.90	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	57.96	4.05	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	42.55	2.41	3.02
CD14+ monocytes - mock treated, donor3	11883-125D2	47.85	4.74	2.84
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	37.50	3.52	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	36.71	2.76	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	47.35	1.98	3.47
CD14+ monocytes - treated with BCG, donor1	11860-125A6	47.38	3.92	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	32.76	1.60	2.14
CD14+ monocytes - treated with BCG, donor3	11880-125C8	64.42	6.53	3.26
CD14+ monocytes - treated with Candida, donor1	11868-125B5	29.73	3.98	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	32.74	2.11	4.75
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	4.44	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	45.96	2.83	3.27
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	49.29	3.19	2.99
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	81.82	8.95	4.16
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	45.07	3.43	2.29
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	41.62	3.17	2.94
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.35	2.18	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	38.47	1.88	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	43.27	2.44	2.27
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.09	4.63	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	48.50	2.39	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.48	4.23	2.47
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	44.31	4.39	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.82	2.79	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	30.11	3.35	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	48.50	6.04	4.31
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	44.22	2.87	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.62	2.32	2.78
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	59.62	6.03	3.02
CD14+CD16+ Monocytes, donor1	11789-124B7	55.58	3.71	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	53.13	4.16	2.54
CD14+CD16+ Monocytes, donor3	11912-125G4	56.54	2.60	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	64.00	3.43	1.71
CD14+CD16- Monocytes, donor2	11799-124C8	62.00	4.02	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	62.21	3.79	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	52.31	1.79	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	64.11	3.29	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	61.27	4.00	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	79.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	96.95	8.81	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	111.84	9.32	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	132.73	9.06	3.20
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	105.61	6.97	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	103.18	6.32	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	92.55	8.63	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	85.69	3.95	2.64
CD19+ B Cells, donor1	11544-120B5	16.44	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	9.43	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	7.07	0.50	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	199.20	15.35	16.16
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	151.41	12.38	14.38
CD34+ Progenitors, donor1	11545-120B6	15.06	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	29.21	4.49	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	77.78	6.01	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	101.47	5.64	1.35
CD4+ T Cells, donor1	11225-116C1	23.21	2.14	0.71
CD4+ T Cells, donor2	11306-117C1	19.60	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	12.50	0.91	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	102.35	4.08	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	94.33	3.37	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	92.56	3.74	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	37.93	1.90	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	47.06	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	106.36	5.20	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	59.65	1.36	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	47.88	2.26	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.21	0.45	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	59.75	2.10	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	60.28	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	111.73	3.37	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	70.23	1.87	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	54.13	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	65.81	2.18	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	52.52	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	120.53	4.08	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	98.34	4.12	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	96.25	4.83	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	38.43	1.52	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	59.36	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	64.06	2.61	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	111.84	6.43	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	85.86	5.54	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	80.96	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	130.99	7.20	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	152.39	7.36	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	106.26	6.16	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	133.22	6.45	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	106.64	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	20.30	1.64	2.29
CD8+ T Cells, donor2	11307-117C2	14.27	0.00	1.50
CD8+ T Cells, donor3	11383-118B6	15.40	1.01	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.72	3.21	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	33.31	1.68	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.57	3.01	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	40.23	3.00	3.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.64	2.40	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.97	1.59	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	34.33	3.91	2.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	37.37	1.84	2.90
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	32.36	2.58	2.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.32	2.11	4.83
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.02	3.20	2.61
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	37.57	3.20	4.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.57	0.88	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.69	1.82	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.90	0.75	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	30.61	3.96	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	30.79	3.74	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	22.63	3.06	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	45.00	3.80	2.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	39.37	3.08	4.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	35.58	2.56	6.09
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	34.04	1.91	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.04	2.76	4.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.77	0.76	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	37.74	1.61	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	31.47	4.90	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	31.05	3.01	1.00
Cardiac Myocyte, donor1	11525-119I4	14.62	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	63.24	4.94	4.94
Cardiac Myocyte, donor3	11686-122I3	108.28	13.79	4.53
Chondrocyte - de diff, donor1	11261-116G1	93.95	9.36	3.47
Chondrocyte - de diff, donor2	11338-117F6	57.57	6.75	2.49
Chondrocyte - de diff, donor3	11410-118E6	71.34	7.85	3.53
Chondrocyte - re diff, donor2	11339-117F7	213.97	20.59	15.22
Chondrocyte - re diff, donor3	11411-118E7	62.68	4.04	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	138.51	16.64	4.82
Ciliary Epithelial Cells, donor2	11323-117D9	84.86	10.90	7.27
Ciliary Epithelial Cells, donor3	11399-118D4	98.14	10.18	5.84
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.75	3.67	1.10
Corneal Epithelial Cells, donor1	11526-119I5	4.61	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.46	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	86.84	3.96	1.82
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	101.88	4.73	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	79.37	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	59.50	2.59	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.91	0.68	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.85	1.96	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	32.42	2.42	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	54.70	7.84	3.50
Endothelial Cells - Aortic, donor1	11263-116G3	22.30	3.52	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	45.25	3.11	3.39
Endothelial Cells - Aortic, donor3	11412-118E8	22.41	3.15	1.97
Endothelial Cells - Artery, donor1	11264-116G4	31.41	4.07	4.07
Endothelial Cells - Artery, donor2	11341-117F9	58.35	6.35	6.82
Endothelial Cells - Artery, donor3	11413-118E9	51.54	5.26	5.26
Endothelial Cells - Lymphatic, donor1	11236-116D3	96.42	8.64	5.54
Endothelial Cells - Lymphatic, donor2	11317-117D3	90.06	14.60	6.69
Endothelial Cells - Lymphatic, donor3	11393-118C7	108.25	13.81	7.61
Endothelial Cells - Microvascular, donor1	11265-116G5	40.41	6.83	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	42.17	7.29	4.69
Endothelial Cells - Microvascular, donor3	11414-118F1	23.11	2.55	1.99
Endothelial Cells - Thoracic, donor1	11266-116G6	88.03	13.20	10.80
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	1.57	3.14
Endothelial Cells - Umbilical vein, donor1	11243-116E1	145.00	14.29	9.94
Endothelial Cells - Umbilical vein, donor2	11324-117E1	47.15	4.56	2.17
Endothelial Cells - Umbilical vein, donor3	11400-118D5	51.42	4.64	4.76
Endothelial Cells - Vein, donor1	11267-116G7	23.89	2.28	3.41
Endothelial Cells - Vein, donor2	11344-117G3	25.15	4.89	1.40
Endothelial Cells - Vein, donor3	11416-118F3	33.76	3.93	3.30
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	44.56	1.65	1.65
Eosinophils, donor3	12246-129H5	35.67	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	7.09	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	88.67	8.21	5.75
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	37.34	3.50	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	39.00	3.14	2.71
Fibroblast - Aortic Adventitial, donor1	11245-116E3	140.81	18.43	12.37
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	251.52	28.11	24.02
Fibroblast - Aortic Adventitial, donor2	11326-117E3	78.05	8.54	5.91
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	123.31	14.76	8.96
Fibroblast - Aortic Adventitial, donor3	11401-118D6	94.68	8.30	6.64
Fibroblast - Cardiac, donor1	11268-116G8	64.42	4.99	3.63
Fibroblast - Cardiac, donor2	11345-117G4	44.72	3.03	8.34
Fibroblast - Cardiac, donor3	11417-118F4	56.62	6.15	4.89
Fibroblast - Cardiac, donor4	11452-119A3	147.61	16.97	8.18
Fibroblast - Cardiac, donor5	11456-119A7	73.60	9.39	3.30
Fibroblast - Cardiac, donor6	11460-119B2	80.50	9.10	3.79
Fibroblast - Choroid Plexus, donor1	11492-119E7	42.47	4.96	1.88
Fibroblast - Choroid Plexus, donor2	11572-120E6	73.34	9.92	4.31
Fibroblast - Choroid Plexus, donor3	11653-122E6	96.68	10.25	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	17.99	2.08	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	157.05	14.42	3.56
Fibroblast - Dermal, donor1	11269-116G9	57.29	7.51	3.52
Fibroblast - Dermal, donor2	11346-117G5	47.64	8.02	1.89
Fibroblast - Dermal, donor3	11418-118F5	72.41	7.86	2.78
Fibroblast - Dermal, donor4	11450-119A1	77.55	8.25	3.62
Fibroblast - Dermal, donor5	11454-119A5	73.97	6.98	2.97
Fibroblast - Dermal, donor6	11458-119A9	103.79	11.37	4.06
Fibroblast - Gingival, donor1	11237-116D4	192.40	15.20	6.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	110.04	7.34	4.98
Fibroblast - Gingival, donor2	11318-117D4	114.65	6.59	4.74
Fibroblast - Gingival, donor3	11394-118C8	96.49	6.86	2.51
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	111.16	9.35	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	52.33	6.17	2.64
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	118.17	8.11	5.46
Fibroblast - Gingival, donor6 (control)	11922-125H5	98.85	7.98	6.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.64	1.41	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	102.52	9.21	6.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	125.17	10.91	6.54
Fibroblast - Gingival, donor8 (control)	11926-125H9	81.94	6.14	5.37
Fibroblast - Gingival, donor9 (control)	11927-125I1	77.62	8.80	3.08
Fibroblast - Lung, donor1	11270-116H1	23.11	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	108.93	7.46	1.49
Fibroblast - Lung, donor3	11419-118F6	71.54	5.06	2.74
Fibroblast - Lymphatic, donor1	11506-119G3	15.83	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.80	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	43.03	2.44	1.62
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	207.16	14.35	6.79
Fibroblast - Periodontal Ligament, donor2	11319-117D5	124.83	9.40	5.31
Fibroblast - Periodontal Ligament, donor3	11395-118C9	189.10	21.73	8.57
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	67.93	3.43	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	101.52	8.10	5.13
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	52.54	5.22	1.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	132.86	14.92	11.50
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	24.79	2.44	3.25
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	15.37	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	76.70	5.93	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	213.33	21.43	10.12
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	133.04	10.66	4.97
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	167.72	13.40	7.49
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	145.31	15.64	7.52
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	196.58	23.64	7.45
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	247.51	22.02	8.10
Fibroblast - skin normal, donor1	11553-120C5	158.50	10.50	5.91
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	249.43	24.26	11.23
Fibroblast - skin normal, donor2	11561-120D4	187.56	17.28	6.83
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	280.17	28.71	12.69
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	164.95	15.08	6.13
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	211.29	22.91	5.81
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	167.50	23.65	8.21
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	182.15	21.09	8.20
Fibroblast - skin walker warburg, donor1	11554-120C6	154.17	14.00	8.60
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	95.50	8.63	3.29
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1706.30	66.48	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	28.76	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	86.33	6.93	5.89
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	109.30	13.79	5.47
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	68.22	7.41	4.34
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	55.12	3.06	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	62.53	5.74	5.74
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	72.46	7.42	5.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	60.39	4.96	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.89	3.42	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	50.13	3.17	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	46.26	3.44	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.03	3.59	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	54.84	5.75	4.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	100.62	5.94	5.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	79.06	6.40	3.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	57.49	5.10	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	85.11	6.94	2.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	78.90	5.54	3.05
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	57.13	3.66	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	59.33	5.48	3.65
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	87.07	6.48	3.86
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	59.02	4.15	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	72.10	7.09	3.55
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	92.35	7.79	3.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	67.03	5.14	2.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	61.50	4.23	4.03
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	105.86	9.50	2.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	121.75	13.03	7.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	117.79	11.65	4.79
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	114.93	11.44	4.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	87.42	8.41	4.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	126.87	13.89	5.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	118.22	12.05	6.53
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	75.51	5.98	2.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	96.15	7.03	2.42
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	71.04	6.84	5.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	57.97	3.75	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	102.21	7.26	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	69.54	5.51	2.59
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	73.44	6.74	3.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	76.09	6.73	1.80
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	65.64	4.90	2.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	67.81	7.60	3.65
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	90.22	6.59	2.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	64.33	8.78	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	72.38	8.42	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	76.11	6.57	3.33
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	74.87	7.22	4.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	60.90	5.20	2.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	91.97	8.42	3.89
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	79.70	8.40	3.80
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	80.38	7.37	3.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	85.53	7.46	4.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	84.30	6.94	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	92.21	9.50	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	83.53	7.26	3.83
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	129.11	8.90	2.80
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	116.45	12.14	5.77
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	84.13	5.85	3.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	90.63	4.91	4.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	66.97	8.45	5.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	61.88	8.48	6.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	57.65	6.92	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	4.95	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	76.20	7.35	7.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	62.57	8.02	12.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	83.46	3.48	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	73.56	10.42	5.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	93.48	10.30	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	10.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	83.89	8.39	6.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	95.11	9.15	7.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	74.66	3.36	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	102.10	9.86	4.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	88.99	9.85	6.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	100.23	10.44	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	101.94	8.59	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	82.58	7.70	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	93.18	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	113.91	12.43	10.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	91.13	10.13	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	15.81	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	83.03	8.84	5.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	103.98	10.76	8.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	74.24	5.35	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	128.68	11.17	5.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	109.21	15.75	15.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	106.85	12.42	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	100.98	5.66	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	97.16	7.85	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	93.60	8.65	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	94.92	11.57	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	134.69	12.33	8.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	110.96	11.80	8.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	105.60	9.92	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	144.83	17.56	6.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	66.97	10.17	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	83.57	7.16	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	81.52	11.65	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	55.92	5.71	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	85.24	6.65	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	43.85	1.12	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	85.63	5.39	3.49
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	63.50	7.94	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	76.94	4.76	4.76
Hep-2 cells mock treated, biol_rep2	11899-125E9	81.87	4.73	3.21
Hep-2 cells mock treated, biol_rep3	11900-125F1	75.08	4.55	2.96
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	84.61	6.56	3.83
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	76.29	3.22	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	76.86	6.24	4.31
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	77.84	4.36	5.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	75.31	2.92	3.09
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	77.85	5.77	4.49
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	2.24	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	18.51	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.57	2.12	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14.53	1.45	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	83.05	6.47	7.69
Hepatocyte, donor1	11523-119I2	72.64	1.21	3.63
Hepatocyte, donor2	11603-120I1	74.34	7.54	1.08
Hepatocyte, donor3	11684-122I1	57.06	3.68	3.68
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	61.35	3.92	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	182.65	14.68	5.94
Iris Pigment Epithelial Cells, donor1	11530-119I9	111.27	12.35	8.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	29.07	4.15	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	2.56	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	6.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	38.35	3.33	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	67.50	6.62	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	39.91	2.22	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.80	5.67	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	3.09	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	68.48	1.94	5.17
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	33.81	3.22	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	70.89	2.44	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	46.18	2.94	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	64.29	4.02	8.04
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	27.70	3.69	5.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	40.12	2.83	4.25
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	20.86	5.44	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	46.27	5.38	7.53
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	1.27	6.35
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	51.65	7.01	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	43.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	56.41	1.43	6.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	56.41	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	41.05	2.78	4.01
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	3.51	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	42.42	6.26	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	16.57	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	25.60	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	19.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	0.00	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	24.85	2.76	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	23.26	1.06	3.17
Keratinocyte - epidermal, donor1	11272-116H3	64.71	6.20	2.53
Keratinocyte - epidermal, donor2	11349-117G8	19.33	0.59	1.17
Keratinocyte - epidermal, donor3	11421-118F8	70.80	4.54	1.80
Keratinocyte - oral, donor1	11251-116E9	120.67	11.58	1.59
Keratocytes, donor1	11527-119I6	17.88	0.34	0.34
Keratocytes, donor2	11607-120I5	8.20	0.00	0.00
Keratocytes, donor3	11688-122I5	47.82	5.53	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	53.94	6.47	7.55
Lens Epithelial Cells, donor2	11609-120I7	95.96	10.61	3.69
Lens Epithelial Cells, donor3	11690-122I7	101.31	16.15	8.68
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	71.38	7.71	2.85
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	37.40	3.91	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	62.18	5.82	2.83
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.72	4.84	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	26.16	2.84	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	34.07	4.20	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	44.73	4.92	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.92	2.02	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	32.79	2.67	2.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.55	2.77	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.75	4.07	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.15	0.74	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	54.35	3.83	2.44
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	35.54	4.77	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	28.02	2.47	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	46.81	5.54	3.08
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	18.39	2.49	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	27.08	3.11	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	42.46	3.95	2.96
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	22.84	2.64	2.05
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.17	1.99	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	46.07	5.82	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	40.13	4.85	1.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	39.81	4.84	2.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	39.40	6.74	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	44.81	3.77	2.93
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	31.43	3.61	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	36.46	3.44	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	35.56	2.82	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.01	2.33	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.89	1.94	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.13	4.96	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.01	2.11	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.45	8.14	4.81
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	34.10	4.45	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.49	3.30	1.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	47.60	5.79	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	39.87	3.35	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	40.87	4.76	3.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	41.96	2.84	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.81	2.91	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.05	1.87	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.45	3.94	2.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	34.95	3.59	3.59
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.60	3.30	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	58.41	8.04	4.95
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.78	1.28	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	20.59	3.28	2.09
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	2.27	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.82	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	34.88	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	41.04	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	40.79	2.81	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	1.87	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.86	2.58	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	33.30	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	55.19	4.52	2.71
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	67.47	1.74	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	62.57	4.50	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	70.18	2.57	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	39.03	0.51	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	53.28	4.23	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.97	1.33	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	44.83	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	62.70	3.47	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	67.64	3.40	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	51.54	1.23	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	46.48	4.08	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	54.98	3.75	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	61.66	2.80	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	45.33	5.15	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	62.71	3.77	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	55.90	1.49	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	59.75	3.32	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	52.67	2.83	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	55.32	1.84	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	34.54	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	40.29	3.45	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	38.50	2.83	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	39.38	4.10	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	35.25	2.71	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	48.12	2.87	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	44.07	0.00	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	44.96	1.11	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	47.38	3.02	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	45.38	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	58.64	1.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	39.22	2.41	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	28.44	2.13	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	42.28	2.06	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	42.40	2.15	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.01	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	50.75	4.07	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	62.80	5.81	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	31.73	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	39.61	2.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	45.07	4.36	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	41.39	3.07	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	45.87	4.44	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	52.69	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	34.19	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	41.46	2.25	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	43.03	6.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	56.56	4.01	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	53.57	5.47	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	49.48	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	44.63	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	50.32	3.50	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	55.91	2.80	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.28	0.88	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	59.01	3.09	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	49.12	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	45.18	1.44	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	50.49	1.59	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	42.53	6.08	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	38.74	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	55.10	1.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	54.22	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	32.65	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	49.75	3.17	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	38.38	0.53	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	28.73	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	51.94	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.10	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	35.18	1.70	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	37.86	3.33	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	35.24	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.48	2.92	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	47.86	1.86	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	41.48	1.34	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.56	2.14	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	48.90	4.04	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.97	0.92	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	37.34	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	43.88	2.85	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	40.65	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	41.04	3.83	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	42.32	2.67	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	71.75	4.68	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	40.45	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	95.95	7.07	0.91
Macrophage - monocyte derived, donor2	11313-117C8	93.04	4.77	0.73
Macrophage - monocyte derived, donor3	11389-118C3	56.63	2.10	1.31
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	82.31	5.84	7.43
Mallassez-derived cells, donor2	11929-125I3	154.17	13.15	12.36
Mallassez-derived cells, donor3	11930-125I4	128.42	11.67	10.01
Mammary Epithelial Cell, donor1	11273-116H4	86.09	8.77	2.79
Mammary Epithelial Cell, donor2	11350-117G9	61.38	4.34	3.47
Mammary Epithelial Cell, donor3	11422-118F9	22.95	2.49	0.75
Mast cell - stimulated, donor1	11487-119E2	333.54	45.42	54.23
Mast cell, donor1	11563-120D6	110.84	22.39	12.98
Mast cell, donor2	11565-120D8	67.76	5.35	3.27
Mast cell, donor3	11566-120D9	85.77	4.73	6.75
Mast cell, donor4	11567-120E1	63.82	4.43	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	197.94	25.06	12.20
Mast cell, expanded and stimulated, donor8	11942-126A7	138.33	23.35	18.68
Mast cell, expanded, donor5	11939-126A4	169.10	20.42	17.44
Mast cell, expanded, donor8	11941-126A6	90.55	12.72	8.70
Melanocyte - dark, donor1	11502-119F8	84.87	11.74	4.28
Melanocyte - dark, donor2	11582-120F7	68.52	7.96	8.65
Melanocyte - dark, donor3	11663-122F7	90.48	11.01	2.25
Melanocyte - light, donor1	11274-116H5	28.21	1.65	0.94
Melanocyte - light, donor2	11351-117H1	28.66	1.36	0.00
Melanocyte - light, donor3	11423-118G1	13.88	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	83.51	6.14	2.29
Melanocyte, donor2 (MC+2)	12739-135I3	73.96	6.45	4.30
Melanocyte, donor3 (MC+3)	12837-137B2	67.77	7.77	2.95
Meningeal Cells, donor1	11493-119E8	39.82	4.09	1.61
Meningeal Cells, donor2	11573-120E7	30.37	3.52	1.32
Meningeal Cells, donor3	11654-122E7	151.27	17.44	9.78
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	181.93	13.97	5.70
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	119.45	12.38	10.16
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	68.89	7.89	4.31
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	129.60	9.95	5.93
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	90.48	9.55	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	28.79	1.54	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.19	2.05	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	170.36	12.60	3.46
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.96	2.23	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	193.94	14.60	8.03
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.13	4.15	2.97
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	3.20	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	173.68	15.95	9.92
Mesenchymal stem cells - hepatic, donor0	11218-116B3	198.27	17.83	5.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	62.41	5.81	1.45
Mesothelial Cells, donor1	11247-116E5	117.47	11.67	7.69
Mesothelial Cells, donor2	12156-128G5	92.59	6.01	6.01
Mesothelial Cells, donor3	11402-118D7	62.08	6.79	3.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	52.95	4.19	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	58.89	2.94	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	48.35	2.79	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	49.37	3.11	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	51.30	6.26	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	53.53	3.26	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	46.13	3.25	1.63
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	50.68	2.77	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	48.67	4.42	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	70.29	3.80	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.81	3.61	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	2.76	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	32.19	1.79	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	40.90	2.76	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	44.92	2.61	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.37	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	48.12	3.22	2.30
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	54.27	3.58	2.31
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	41.99	2.45	1.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	52.13	2.15	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	37.34	2.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	37.01	2.85	3.07
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.36	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	38.05	3.81	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	38.23	2.94	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	48.54	2.40	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	53.23	2.40	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	50.06	2.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	50.36	4.38	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	1.28	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	57.27	3.72	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	42.39	4.10	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.00	0.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.04	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	52.18	3.93	3.37
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.86	2.49	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	31.67	3.32	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	42.57	2.92	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	32.32	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	32.44	1.14	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.99	3.04	1.52
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.28	2.59	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	26.60	4.29	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	22.15	2.40	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	47.59	2.10	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.30	2.26	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	50.33	3.50	2.87
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	50.42	2.65	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.79	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	49.72	5.40	1.99
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	50.88	2.70	2.70
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	42.63	3.53	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	57.67	2.88	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	50.28	4.95	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	39.01	2.38	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	67.80	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	33.86	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	53.23	2.63	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	57.86	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	55.95	1.98	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	34.46	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	51.07	2.25	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	42.08	2.40	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	75.33	4.98	1.70
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	26.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	39.21	2.56	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	45.43	1.60	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	48.48	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	31.20	2.53	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	14.58	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	114.83	11.85	10.13
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	71.08	4.18	4.18
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	2.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.51	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	55.71	4.56	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	39.90	14.36	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	181.93	27.56	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.76	3.35	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.78	2.79	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.65	2.16	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	50.25	3.78	1.89
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	400.85	66.81	55.67
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	43.18	1.99	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	40.06	3.52	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.92	1.59	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	21.23	2.29	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	64.15	7.65	2.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	32.89	0.53	4.77
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.61	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	75.48	5.25	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.12	1.14	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	54.15	4.06	3.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	35.86	1.41	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	21.15	1.84	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.99	2.57	2.57
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	85.19	9.31	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	189.63	15.17	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.31	3.79	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.78	1.27	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.60	1.90	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.35	3.43	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	496.53	81.25	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.99	1.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	26.15	2.71	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.16	1.19	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	39.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	36.32	6.43	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.62	2.28	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.33	0.87	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	50.66	1.81	4.07
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	1.76	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	33.24	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	32.74	1.49	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.87	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	65.93	7.26	3.02
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	59.90	7.74	4.20
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.07	1.36	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	224.82	20.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	36.58	3.05	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.31	2.52	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.86	2.12	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	34.81	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	78.22	5.67	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	323.70	55.64	5.06
Myoblast, donor1	11241-116D8	154.04	18.14	15.16
Myoblast, donor2	11322-117D8	95.32	11.51	4.22
Myoblast, donor3	11398-118D3	132.85	14.80	7.06
NK T cell leukemia cell line:KHYG-1	10777-110G3	42.76	2.77	0.58
Natural Killer Cells, donor1	11230-116C6	26.45	1.54	2.77
Natural Killer Cells, donor2	11311-117C6	18.09	1.21	1.51
Natural Killer Cells, donor3	11387-118C1	20.43	1.66	2.02
Neural stem cells, donor1	11275-116H6	132.47	18.15	7.98
Neural stem cells, donor2	11352-117H2	113.61	17.33	5.78
Neurons, donor1	11494-119E9	62.58	7.97	2.28
Neurons, donor2	11574-120E8	89.83	9.69	2.42
Neurons, donor3	11655-122E8	56.73	6.58	4.11
Neutrophils, donor1	11233-116C9	27.84	2.78	1.86
Neutrophils, donor2	11314-117C9	28.99	0.00	8.70
Neutrophils, donor3	11390-118C4	65.36	1.83	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	150.79	14.96	2.73
Nucleus Pulposus Cell, donor2	11409-118E5	34.84	3.91	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	46.33	5.01	1.20
Olfactory epithelial cells, donor1	11933-125I7	50.66	5.51	2.34
Olfactory epithelial cells, donor2	11934-125I8	93.94	7.09	4.49
Olfactory epithelial cells, donor3	11935-125I9	68.10	6.02	3.29
Olfactory epithelial cells, donor4	11936-126A1	76.55	6.33	2.73
Oligodendrocyte - precursors, donor1	11496-119F2	133.00	15.05	6.62
Osteoblast - differentiated, donor1	11276-116H7	63.81	7.23	1.91
Osteoblast - differentiated, donor2	11353-117H3	30.86	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	18.00	3.72	0.00
Osteoblast, donor1	11277-116H8	71.33	7.82	3.91
Osteoblast, donor2	11354-117H4	168.56	19.66	11.94
Osteoblast, donor3	11426-118G4	71.80	7.29	3.73
Pancreatic stromal cells, donor1	11249-116E7	188.52	15.67	6.65
Pericytes, donor1	11491-119E6	10.46	1.00	0.78
Pericytes, donor2	11571-120E5	8.15	1.13	0.23
Pericytes, donor3	11652-122E5	14.85	2.03	0.20
Perineurial Cells, donor1	11499-119F5	157.89	16.84	6.67
Perineurial Cells, donor2	11579-120F4	132.96	15.46	9.02
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	37.93	1.91	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	17.39	0.98	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.25	1.04	0.91
Placental Epithelial Cells, donor1	11278-116H9	48.79	4.07	0.48
Placental Epithelial Cells, donor2	11355-117H5	73.19	4.44	2.22
Placental Epithelial Cells, donor3	11427-118G5	39.07	3.53	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	44.94	2.53	4.43
Preadipocyte - breast, donor1	11467-119B9	132.62	16.32	6.57
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	285.33	35.11	15.53
Preadipocyte - breast, donor2	11328-117E5	81.73	7.88	4.05
Preadipocyte - omental, donor1	11468-119C1	147.05	15.02	8.52
Preadipocyte - omental, donor2	11329-117E6	155.82	17.02	11.78
Preadipocyte - omental, donor3	11403-118D8	117.75	11.32	7.02
Preadipocyte - perirenal, donor1	11469-119C2	54.13	4.92	6.89
Preadipocyte - subcutaneous, donor1	11279-116I1	60.50	8.60	5.22
Preadipocyte - subcutaneous, donor2	11356-117H6	128.38	11.51	10.62
Preadipocyte - subcutaneous, donor3	11428-118G6	121.24	13.45	8.34
Preadipocyte - visceral, donor1	11280-116I2	176.05	19.37	12.20
Preadipocyte - visceral, donor2	11357-117H7	105.84	5.98	8.28
Preadipocyte - visceral, donor3	11429-118G7	88.71	7.94	5.54
Prostate Epithelial Cells (polarized), donor1	11253-116F2	127.62	10.56	4.53
Prostate Epithelial Cells, donor2	11331-117E8	51.73	3.79	4.20
Prostate Epithelial Cells, donor3	11404-118D9	42.87	1.96	1.16
Prostate Stromal Cells, donor1	11254-116F3	163.45	16.97	8.88
Prostate Stromal Cells, donor2	11332-117E9	109.55	8.43	6.99
Prostate Stromal Cells, donor3	11405-118E1	96.77	10.84	6.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.50	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	81.23	7.42	2.77
Renal Epithelial Cells, donor1	11517-119H5	5.07	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	91.68	11.33	3.92
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.19	0.67	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	43.29	3.55	3.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	20.91	1.76	1.76
Renal Mesangial Cells, donor2	11598-120H5	6.90	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.66	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.55	1.88	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.23	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.99	1.16	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	138.98	9.33	2.85
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.63	1.14	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	51.19	6.52	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	110.52	5.61	2.41
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	51.82	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	143.10	4.95	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	86.43	4.64	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	122.09	9.88	5.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	83.32	4.17	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	150.69	11.38	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	169.07	11.66	5.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	97.78	7.58	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	125.50	5.55	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	66.67	6.43	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	90.76	6.50	3.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	115.04	8.96	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	75.17	9.76	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	89.39	5.58	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	92.71	6.64	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	65.76	5.74	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	83.01	5.50	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	160.85	12.21	5.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	63.43	4.78	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	90.62	5.45	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	113.81	9.74	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	71.34	4.49	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	77.92	4.48	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	91.43	5.64	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	66.37	5.65	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	82.29	3.68	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	106.78	6.58	3.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	91.28	8.49	3.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	88.10	4.56	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	105.70	6.55	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	82.11	6.43	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	89.15	5.31	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	80.21	5.64	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	85.19	7.40	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	70.16	4.94	3.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	96.59	6.56	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	93.53	5.85	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	67.90	4.94	2.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	106.38	5.09	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	61.36	5.28	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	114.96	7.99	3.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	74.63	6.93	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	52.40	5.81	1.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	82.15	7.62	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	86.06	5.64	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	66.86	4.99	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	93.98	6.64	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	61.05	2.12	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	76.86	6.49	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	131.29	9.02	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	80.92	6.08	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	76.25	6.33	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	74.64	3.62	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	98.55	5.09	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	101.90	9.33	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	74.49	5.76	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	69.11	6.01	4.21
Schwann Cells, donor1	11498-119F4	9.78	0.56	0.38
Schwann Cells, donor2	11578-120F3	61.24	3.40	6.80
Schwann Cells, donor3	11659-122F3	73.17	6.35	2.63
Sebocyte, donor1	11220-116B5	69.02	4.93	3.83
Sebocyte, donor2	11301-117B5	21.60	3.22	2.30
Sebocyte, donor3	11378-118B1	35.04	2.89	1.24
Sertoli Cells, donor1	11255-116F4	145.78	9.94	9.94
Sertoli Cells, donor2	11333-117F1	76.26	2.82	8.47
Skeletal Muscle Cells, donor1	11281-116I3	70.29	7.21	1.76
Skeletal Muscle Cells, donor2	11358-117H8	6.51	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.10	3.34	1.67
Skeletal Muscle Cells, donor4	11451-119A2	95.51	9.43	5.03
Skeletal Muscle Cells, donor5	11455-119A6	86.81	8.62	4.31
Skeletal Muscle Cells, donor6	11459-119B1	90.19	8.16	4.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	208.92	19.78	6.55
Skeletal Muscle Satellite Cells, donor2	11321-117D7	109.44	8.99	4.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	103.87	10.32	5.36
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	133.37	12.30	6.74
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	2.90	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	29.31	4.68	1.79
Skin - palm, donor1	10286-104F7	10.74	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.59	2.02	1.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	75.25	4.09	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.08	2.47	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	91.88	9.04	4.87
Small Airway Epithelial Cells, donor2	11334-117F2	32.35	3.09	3.09
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	120.52	10.36	5.92
Small Airway Epithelial Cells, donor3	11406-118E2	36.35	1.80	1.27
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	43.82	6.48	6.17
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	150.07	18.23	13.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	92.29	11.76	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	66.74	8.18	4.86
Smooth Muscle Cells - Aortic, donor2	11360-117I1	64.58	8.27	11.03
Smooth Muscle Cells - Aortic, donor3	11432-118H1	91.16	11.59	6.18
Smooth Muscle Cells - Bladder, donor1	11519-119H7	63.05	9.01	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	112.98	12.91	8.12
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	107.95	10.64	8.64
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	72.59	8.96	11.14
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	158.24	16.28	7.49
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	164.50	21.26	10.93
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	71.32	7.12	4.98
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.81	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	26.18	1.83	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	82.84	9.09	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	48.16	5.72	4.77
Smooth Muscle Cells - Colonic, donor1	11239-116D6	175.20	13.27	6.93
Smooth Muscle Cells - Colonic, donor2	11320-117D6	102.88	7.75	4.74
Smooth Muscle Cells - Colonic, donor3	11396-118D1	103.59	10.81	6.09
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	64.66	8.35	7.42
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	49.58	5.39	8.62
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	40.64	6.87	4.78
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.51	2.39	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	164.13	14.21	4.48
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	155.09	20.03	12.98
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	85.79	12.97	8.19
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	43.47	3.62	4.83
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	132.99	15.90	7.68
Smooth Muscle Cells - Prostate, donor1	11257-116F6	180.03	17.18	10.52
Smooth Muscle Cells - Prostate, donor2	11335-117F3	109.19	11.90	7.51
Smooth Muscle Cells - Prostate, donor3	11465-119B7	96.65	7.86	4.31
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	142.18	15.38	9.50
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	35.26	3.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	52.98	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	82.32	10.70	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	96.43	10.10	10.60
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	59.54	7.83	10.66
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.62	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	115.30	12.25	5.66
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	61.20	5.14	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	69.66	7.48	5.90
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	52.27	5.35	4.33
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	33.85	4.32	2.26
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	168.53	17.75	8.38
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	142.61	14.83	6.95
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.38	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	70.95	7.10	7.83
Smooth Muscle Cells - Uterine, donor1	11258-116F7	157.09	14.36	10.38
Smooth Muscle Cells - Uterine, donor3	11466-119B8	102.70	9.95	3.80
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	61.81	4.66	2.92
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	67.70	5.82	5.02
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	168.12	11.90	5.21
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	101.33	9.34	7.91
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	75.80	5.39	4.54
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	83.50	6.70	4.73
Smooth muscle cells - airway, control, donor1	11966-126D4	81.52	4.57	4.06
Smooth muscle cells - airway, control, donor2	11967-126D5	58.70	5.59	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	59.77	6.69	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	73.34	4.13	0.46
Synoviocyte, donor1	11291-117A4	150.98	13.97	7.74
Synoviocyte, donor2	11368-117I9	65.21	5.87	2.01
Synoviocyte, donor3	11440-118H9	50.71	3.57	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	19.65	3.93	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.76	3.24	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	51.33	5.02	2.22
Tracheal Epithelial Cells, donor2	11369-118A1	19.71	0.39	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	16.03	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	105.19	6.03	1.97
Urethra, donor2	10319-105A4	25.18	0.00	0.00
Urothelial Cells, donor1	11520-119H8	10.63	0.27	0.53
Urothelial Cells, donor2	11600-120H7	5.21	0.00	0.40
Urothelial Cells, donor3	11681-122H7	5.96	0.69	0.00
Urothelial cells, donor0	11216-116B1	139.53	10.25	2.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	114.78	8.01	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	104.36	11.44	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.97	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	97.10	4.13	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	96.45	3.49	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	119.74	4.16	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	104.63	8.26	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	67.23	5.06	1.85
Wilms' tumor cell line:HFWT	10597-108E3	15.84	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	77.65	5.31	1.68
achilles tendon, donor2	10292-104G4	18.60	4.13	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	156.29	7.65	3.06
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	103.55	6.04	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	118.47	5.70	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	151.02	5.44	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	74.77	6.18	3.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	89.88	6.13	2.96
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	87.11	5.72	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	84.60	3.53	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	75.14	2.04	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	55.91	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	63.30	2.76	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	82.73	4.65	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	89.58	2.85	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	73.65	2.92	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	58.56	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	76.90	2.47	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	20.57	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	146.36	5.97	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	141.94	7.89	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	131.18	4.33	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	61.48	3.79	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	54.70	4.34	3.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	72.32	10.17	10.17
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	60.62	2.18	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	69.00	2.83	1.41
adipose tissue, adult, pool1	10010-101C1	66.39	3.88	1.09
adipose, donor1	10184-103D4	107.31	8.21	2.93
adipose, donor2	10185-103D5	36.50	3.24	0.41
adipose, donor3	10186-103D6	47.92	3.54	1.91
adipose, donor4	10187-103D7	51.14	3.47	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	36.93	2.05	0.16
adrenal gland, adult, pool1	10081-102A9	29.10	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	59.37	3.20	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	54.67	3.57	2.14
amniotic membrane cells, donor1	12235-129G3	95.29	5.10	3.01
amniotic membrane cells, donor2	12236-129G4	140.99	11.50	0.68
amniotic membrane cells, donor3	12237-129G5	88.67	3.54	1.47
amygdala - adult, donor10196	10167-103B5	65.22	1.19	2.37
amygdala, adult, donor10252	10151-102I7	72.59	4.66	1.22
amygdala, newborn, donor10223	10360-105E9	38.73	1.61	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	141.97	14.01	5.60
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	74.79	5.96	3.31
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	66.47	5.34	3.01
aorta, adult, pool1	10052-101G7	41.97	3.33	0.59
appendix, adult	10189-103D9	65.20	2.72	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	71.88	5.85	3.44
artery, adult	10190-103E1	25.82	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	154.86	18.98	6.52
b cell line:RPMI1788	10427-106D4	238.07	14.28	4.76
basal cell carcinoma cell line:TE 354.T	10702-109G9	136.50	17.20	5.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	92.38	6.45	3.18
bile duct carcinoma cell line:TFK-1	10496-107C1	103.11	5.02	2.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	45.86	0.56	0.56
bladder, adult, pool1	10011-101C2	70.51	4.13	0.76
blood, adult, pool1	10053-101G8	19.93	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	81.35	5.99	4.28
bone marrow, adult	10192-103E3	56.69	3.37	4.05
brain, adult, donor1	10084-102B3	36.90	2.05	1.03
brain, adult, pool1	10012-101C3	61.80	4.12	1.56
brain, fetal, pool1	10085-102B4	29.39	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	48.89	1.98	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	140.18	7.61	3.62
breast, adult, donor1	10080-102A8	32.20	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	70.00	2.79	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	45.15	3.71	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	141.82	5.76	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	74.08	3.15	0.97
carcinoid cell line:NCI-H1770	10703-109H1	77.11	5.64	1.41
carcinoid cell line:NCI-H727	10735-110B6	44.41	3.28	2.52
carcinoid cell line:SK-PN-DW	10719-109I8	78.91	3.17	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	59.89	4.26	2.13
caudate nucleus - adult, donor10196	10177-103C6	77.14	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	75.46	4.52	0.84
caudate nucleus, adult, donor10258	10379-105H1	32.09	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	52.37	2.20	0.73
cerebellum - adult, donor10196	10173-103C2	148.58	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	141.98	9.18	1.49
cerebellum, adult, pool1	10083-102B2	39.32	3.10	0.69
cerebellum, newborn, donor10223	10357-105E6	88.01	4.98	0.83
cerebral meninges, adult	10188-103D8	40.59	2.27	0.00
cerebrospinal fluid, donor2	10294-104G6	8.77	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	139.33	13.95	4.89
cervical cancer cell line:ME-180	10553-107I4	100.92	10.94	1.66
cervix, adult, pool1	10013-101C4	90.50	7.03	1.78
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	159.26	16.58	7.52
chondrosarcoma cell line:SW 1353	10700-109G7	31.35	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	108.74	4.23	3.36
choriocarcinoma cell line:SCH	10785-110H2	84.03	5.91	2.22
choriocarcinoma cell line:T3M-3	10618-108G6	46.01	3.08	0.47
chorionic membrane cells, donor1	12238-129G6	98.30	7.98	1.14
chorionic membrane cells, donor2	12239-129G7	170.43	16.51	8.05
chorionic membrane cells, donor3	12240-129G8	98.36	12.09	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	45.44	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	72.23	2.88	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	43.29	3.59	2.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	56.24	5.65	6.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	60.71	6.05	6.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	65.16	5.50	6.72
chronic myelogenous leukemia cell line:K562	10454-106G4	55.36	4.12	7.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	86.01	10.43	5.47
clear cell carcinoma cell line:JHOC-5	10638-108I8	96.00	3.89	2.06
clear cell carcinoma cell line:TEN	10636-108I6	125.10	6.94	6.42
colon carcinoma cell line:CACO-2	10513-107D9	126.48	8.97	7.32
colon carcinoma cell line:COLO-320	10420-106C6	243.25	11.40	4.18
colon, adult, donor1	10082-102B1	42.84	2.38	0.00
colon, adult, pool1	10014-101C5	65.45	4.94	2.35
colon, fetal, donor1	10070-101I7	36.46	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	115.58	8.07	9.35
cord blood derived cell line:COBL-a 24h infection	10453-106G3	111.84	11.47	7.85
cord blood derived cell line:COBL-a untreated	10449-106F8	128.60	12.13	9.17
corpus callosum, adult, pool1	10042-101F6	79.60	4.75	1.44
cruciate ligament, donor2	10295-104G7	38.09	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	48.96	1.61	0.00
diencephalon, adult	10193-103E4	41.76	2.40	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	67.96	2.53	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	120.53	7.44	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	78.48	10.35	1.93
ductus deferens, adult	10196-103E7	108.64	5.48	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	60.49	7.20	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	100.78	9.56	5.89
dura mater, adult, donor1	10041-101F5	65.57	4.29	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	51.74	7.11	3.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	103.89	13.47	5.02
embryonic pancreas cell line:1B2C6	10604-108F1	19.12	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	26.03	1.82	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.08	1.54	0.93
embryonic pancreas cell line:2C6	10603-108E9	19.70	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	122.01	5.36	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	101.67	6.34	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	77.19	9.49	6.11
epidermoid carcinoma cell line:A431	10426-106D3	114.83	7.89	2.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	66.54	6.05	2.31
epididymis, adult	10197-103E8	86.24	5.65	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	73.80	6.39	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	27.13	1.57	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	94.62	5.64	4.06
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	91.04	5.91	2.95
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	92.20	5.15	4.15
esophagus, adult, pool1	10015-101C6	66.79	4.25	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	136.01	6.01	1.13
eye - muscle inferior rectus, donor1	10272-104E2	26.56	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	0.00	0.00
eye - muscle medial, donor2	10299-104H2	19.35	1.49	0.00
eye - muscle superior, donor2	10297-104G9	16.05	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	26.23	0.00	1.46
eye, fetal, donor1	10054-101G9	71.44	5.59	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	67.57	7.82	2.18
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	50.10	2.14	1.90
frontal lobe, adult, pool1	10040-101F4	91.01	6.85	1.69
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	154.03	7.21	5.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	191.10	12.89	4.94
gall bladder, adult	10198-103E9	44.91	4.83	0.97
gamma delta positive T cells, donor1	11937-126A2	96.10	6.98	0.00
gamma delta positive T cells, donor2	11938-126A3	55.65	4.86	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	85.75	7.39	3.17
gastric adenocarcinoma cell line:MKN45	10612-108F9	83.17	4.06	1.74
gastric cancer cell line:AZ521	10549-107H9	97.39	8.36	3.28
gastric cancer cell line:GSS	10560-108A2	36.61	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	69.45	5.94	4.11
giant cell carcinoma cell line:LU65	10487-107B1	64.14	6.65	3.67
giant cell carcinoma cell line:Lu99B	10433-106E1	122.88	10.50	2.66
glassy cell carcinoma cell line:HOKUG	10688-109F4	66.35	3.49	2.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	106.92	8.44	4.01
glioblastoma cell line:A172, tech_rep2	10444-106F3	102.94	10.25	3.37
glioblastoma cell line:T98G	10485-107A8	115.78	9.93	3.64
glioma cell line:GI-1	10413-106B8	98.70	8.49	2.93
globus pallidus - adult, donor10196	10175-103C4	30.61	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	88.61	4.88	0.98
globus pallidus, adult, donor10258	10367-105F7	27.38	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	35.71	3.73	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	46.40	4.80	3.20
hIPS +CCl2, biol_rep1	14383-156B9	65.65	3.67	1.84
hIPS +CCl2, biol_rep2	14384-156C1	54.87	1.83	6.40
hIPS +CCl2, biol_rep3	14385-156C2	48.31	1.93	2.58
hIPS, biol_rep1	14380-156B6	50.31	0.00	11.50
hIPS, biol_rep2	14381-156B7	43.21	3.43	2.06
hIPS, biol_rep3	14382-156B8	30.90	4.41	2.21
hairy cell leukemia cell line:Mo	10712-109I1	49.71	3.74	2.01
heart - mitral valve, adult	10205-103F7	63.68	5.38	1.49
heart - pulmonic valve, adult	10206-103F8	52.30	2.35	0.26
heart - tricuspid valve, adult	10207-103F9	44.13	5.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	47.55	4.29	1.02
heart, adult, diseased, donor1	10051-101G6	36.62	1.28	0.00
heart, adult, pool1	10016-101C7	34.27	2.07	0.69
heart, fetal, pool1	10046-101G1	89.95	5.13	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	75.28	4.63	3.70
hepatoblastoma cell line:HuH-6	10633-108I3	32.11	0.00	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	120.44	10.28	5.75
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	134.48	12.74	6.80
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	130.66	12.53	8.59
hepatoma cell line:Li-7	10484-107A7	95.20	10.45	3.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	77.08	4.32	2.11
hippocampus - adult, donor10196	10169-103B7	59.62	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	79.80	7.35	0.41
hippocampus, adult, donor10258	10374-105G5	41.83	1.49	0.50
hippocampus, newborn, donor10223	10363-105F3	31.02	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	131.83	7.32	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	55.57	4.12	4.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	59.67	3.30	3.30
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	46.80	3.38	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.22	2.32	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	63.02	5.31	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	55.18	3.21	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	59.03	3.88	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	58.81	3.75	4.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	99.93	12.08	4.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	72.97	6.27	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	94.94	8.75	8.08
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	60.25	4.54	2.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	76.64	1.97	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	89.02	10.47	13.09
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	54.60	4.58	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	33.58	2.18	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	50.98	7.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	58.21	6.97	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	55.48	2.73	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	62.02	1.88	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	80.34	8.98	4.08
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	78.38	5.81	3.48
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	73.54	5.98	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	67.06	6.28	4.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	55.63	5.14	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	92.28	4.08	6.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	60.91	6.69	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	55.75	3.48	4.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	61.43	4.24	4.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	58.95	4.14	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	61.10	7.31	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	70.29	3.33	2.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	74.14	8.44	5.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	87.08	6.82	5.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	83.68	7.73	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	59.89	5.80	5.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	71.75	5.35	4.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	84.88	8.29	5.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	67.85	5.50	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	592.09	45.55	26.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	90.68	5.30	6.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	82.09	4.38	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	56.45	3.62	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	54.45	4.63	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	58.48	5.97	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	117.82	10.56	6.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	60.08	5.39	2.69
immature langerhans cells, donor1	11904-125F5	38.74	3.15	5.33
immature langerhans cells, donor2	11905-125F6	17.43	0.00	0.00
insula, adult, pool1	10039-101F3	77.69	6.72	1.99
keratoacanthoma cell line:HKA-1	10791-110H8	75.76	5.20	1.95
kidney, adult, pool1	10017-101C8	106.44	7.41	2.50
kidney, fetal, pool1	10045-101F9	55.03	3.68	0.92
large cell lung carcinoma cell line:IA-LM	10509-107D5	101.40	9.09	4.26
large cell lung carcinoma cell line:NCI-H460	10839-111E2	43.55	4.42	1.66
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	75.97	3.30	3.67
left atrium, adult, donor1	10079-102A7	40.86	1.09	1.63
left ventricle, adult, donor1	10078-102A6	28.32	1.52	0.51
leiomyoblastoma cell line:G-402	10721-110A1	37.76	3.56	2.74
leiomyoma cell line:10964C	10569-108B2	81.55	7.54	3.59
leiomyoma cell line:15242A	10570-108B3	87.50	7.07	11.96
leiomyoma cell line:15425	10571-108B4	113.88	10.20	6.80
leiomyosarcoma cell line:Hs 5.T	10722-110A2	126.99	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	28.23	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	44.39	7.44	4.60
liposarcoma cell line:KMLS-1	10782-110G8	104.35	6.72	3.28
liposarcoma cell line:SW 872	10726-110A6	56.53	3.78	1.95
liver, adult, pool1	10018-101C9	118.14	11.18	12.15
liver, fetal, pool1	10086-102B5	28.22	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	32.23	2.77	1.02
locus coeruleus, adult, donor10252	10165-103B3	69.39	5.91	1.29
locus coeruleus, adult, donor10258	10375-105G6	27.65	3.67	0.85
locus coeruleus, newborn, donor10223	10362-105F2	87.07	6.73	2.52
lung adenocarcinoma cell line:A549	10499-107C4	60.20	3.18	1.52
lung adenocarcinoma cell line:PC-14	10408-106B3	75.83	4.14	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	48.38	1.58	1.45
lung, adult, pool1	10019-101D1	62.84	3.78	1.06
lung, fetal, donor1	10068-101I5	144.70	11.13	1.43
lung, right lower lobe, adult, donor1	10075-102A3	40.32	4.12	1.37
lymph node, adult, donor1	10077-102A5	32.19	3.31	1.42
lymphangiectasia cell line:DS-1	10727-110A7	98.63	9.86	3.51
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	115.91	9.66	3.32
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	106.19	10.19	2.55
mature adipocyte, donor1	12231-129F8	55.94	5.77	1.33
mature adipocyte, donor2	12232-129F9	69.94	4.15	1.45
mature adipocyte, donor3	12233-129G1	79.65	6.40	3.32
mature adipocyte, donor4	12234-129G2	81.33	3.16	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	143.19	10.72	2.14
medial frontal gyrus - adult, donor10196	10170-103B8	76.71	7.90	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	76.14	4.97	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	34.31	2.54	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	109.18	6.40	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	70.71	4.73	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	77.25	5.31	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	516.73	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	37.69	2.15	2.51
medulla oblongata - adult, donor10196	10174-103C3	72.04	3.89	3.24
medulla oblongata, adult, donor10252	10155-103A2	94.28	6.50	0.62
medulla oblongata, adult, pool1	10038-101F2	69.46	5.14	1.14
medulla oblongata, newborn, donor10223	10361-105F1	51.04	1.04	1.04
medulloblastoma cell line:D283 Med	10838-111E1	81.26	8.64	1.99
medulloblastoma cell line:ONS-76	10759-110E3	43.04	3.91	1.35
melanoma cell line:COLO 679	10514-107E1	95.59	8.48	4.02
melanoma cell line:G-361	10465-106H6	155.82	12.49	7.87
meningioma cell line:HKBMM	10691-109F7	73.63	5.25	3.26
merkel cell carcinoma cell line:MKL-1	10843-111E6	83.71	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	98.50	6.48	2.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	177.68	23.17	10.28
mesenchymal precursor cell - adipose, donor2	11748-123G2	113.79	11.63	7.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	101.04	10.77	6.63
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	118.70	14.89	7.02
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	96.48	13.67	5.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	125.63	10.41	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	73.29	8.75	5.32
mesenchymal precursor cell - cardiac, donor2	11753-123G7	81.66	8.05	5.41
mesenchymal precursor cell - cardiac, donor3	11754-123G8	116.32	15.39	8.62
mesenchymal precursor cell - cardiac, donor4	11755-123G9	120.19	15.53	8.64
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	131.74	15.79	13.94
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	70.81	7.25	4.61
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	124.26	12.45	9.41
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	115.55	7.68	5.93
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	118.82	15.52	7.55
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	80.52	6.83	5.03
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	89.79	8.38	3.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	81.17	8.21	6.38
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	179.57	16.78	10.07
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	107.89	12.70	8.22
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	101.97	12.52	7.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	79.52	7.36	4.42
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	92.71	11.16	7.73
mesenchymal stem cell line:Hu5/E18	10568-108B1	95.57	6.74	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	84.94	5.48	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	115.87	9.21	4.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	94.49	7.07	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	105.06	11.40	3.08
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	108.03	8.94	4.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	97.81	9.14	4.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	99.03	7.47	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	100.55	6.95	4.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	137.58	9.81	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	109.99	9.15	4.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	101.19	8.65	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	107.07	5.87	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	103.38	8.06	3.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	104.80	7.78	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	116.41	7.30	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	109.38	8.20	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	118.79	10.33	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	94.19	6.50	3.90
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	100.39	10.18	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	74.10	6.93	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	75.23	11.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	81.24	5.05	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	14.69	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	81.46	6.95	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	95.34	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	77.09	8.30	4.15
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	109.66	9.75	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	79.81	10.77	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	64.50	8.28	3.10
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	68.77	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	87.82	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	66.01	4.89	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	67.53	7.94	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	66.03	4.13	4.13
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	53.61	6.55	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	78.86	12.03	8.02
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	48.49	8.28	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	69.34	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	68.84	8.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	71.25	5.44	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	65.05	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	47.70	3.82	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	59.24	3.63	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	63.24	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	49.42	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	58.26	4.25	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	55.19	6.59	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	70.64	6.55	2.98
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	49.32	2.92	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	55.01	4.07	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	39.46	8.51	3.87
mesothelioma cell line:ACC-MESO-1	10493-107B7	103.47	8.50	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	175.15	12.28	6.72
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	4.27	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	86.62	8.32	4.21
mesothelioma cell line:Mero-25	10850-111F4	78.07	5.90	4.09
mesothelioma cell line:Mero-41	10851-111F5	108.30	8.31	2.93
mesothelioma cell line:Mero-48a	10852-111F6	99.20	9.96	11.74
mesothelioma cell line:Mero-82	10853-111F7	73.32	4.99	4.20
mesothelioma cell line:Mero-83	10854-111F8	98.73	6.30	5.11
mesothelioma cell line:Mero-84	10855-111F9	75.07	6.32	1.77
mesothelioma cell line:Mero-95	10856-111G1	80.75	6.21	3.11
mesothelioma cell line:NCI-H2052	10847-111F1	66.59	4.47	3.81
mesothelioma cell line:NCI-H226	10846-111E9	96.47	5.79	6.88
mesothelioma cell line:NCI-H2452	10848-111F2	128.80	6.49	2.90
mesothelioma cell line:NCI-H28	10845-111E8	84.23	3.31	2.04
mesothelioma cell line:No36	10857-111G2	72.09	6.20	3.26
mesothelioma cell line:ONE58	10858-111G3	138.19	10.30	14.63
migratory langerhans cells, donor1	11901-125F2	117.26	5.18	1.92
migratory langerhans cells, donor2	11902-125F3	92.20	4.52	1.47
migratory langerhans cells, donor3	11903-125F4	107.51	5.03	2.15
mixed mullerian tumor cell line:HTMMT	10689-109F5	75.42	8.81	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	83.93	7.84	3.39
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	36.17	2.76	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	43.58	3.43	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	132.13	8.87	2.96
myeloma cell line:PCM6	10474-106I6	128.48	10.08	2.57
myxofibrosarcoma cell line:MFH-ino	10600-108E6	40.58	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	52.37	5.30	1.96
nasal epithelial cells, donor1, tech_rep1	12226-129F3	56.72	3.45	1.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	69.79	5.59	1.69
nasal epithelial cells, donor2	12227-129F4	46.92	2.21	1.10
neuroblastoma cell line:CHP-134	10508-107D4	95.25	8.05	2.30
neuroblastoma cell line:NB-1	10539-107G8	99.53	13.66	6.17
neuroblastoma cell line:NBsusSR	10607-108F4	82.46	4.85	2.32
neuroblastoma cell line:NH-12	10555-107I6	61.68	4.66	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	48.16	3.32	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	58.13	4.12	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	74.87	4.23	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	25.43	1.91	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	98.75	9.58	6.65
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	218.33	7.95	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	79.25	4.80	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	101.63	9.94	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	103.79	8.93	6.83
nucleus accumbens, adult, pool1	10037-101F1	80.62	6.75	1.59
occipital cortex - adult, donor10196	10172-103C1	107.14	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	75.14	4.03	0.81
occipital cortex, newborn, donor10223	10355-105E4	49.50	5.10	0.73
occipital lobe, adult, donor1	10076-102A4	41.72	2.89	1.05
occipital lobe, fetal, donor1	10073-102A1	44.20	2.57	0.43
occipital pole, adult, pool1	10036-101E9	39.81	3.63	0.47
olfactory region, adult	10195-103E6	42.60	2.29	1.72
optic nerve, donor1	10277-104E7	26.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	108.78	12.19	4.33
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	124.47	7.28	1.79
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	70.10	4.57	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	64.68	5.20	2.31
osteoclastoma cell line:Hs 706.T	10704-109H2	56.15	3.82	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	22.42	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	128.51	9.97	4.24
ovary, adult, pool1	10020-101D2	86.91	5.07	2.10
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.15	4.58	1.65
pancreas, adult, donor1	10049-101G4	130.75	6.58	23.52
pancreatic carcinoma cell line:NOR-P1	10698-109G5	64.85	3.63	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	98.12	7.67	3.92
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	100.01	8.94	7.45
paracentral gyrus, adult, pool1	10035-101E8	71.84	5.77	1.65
parietal cortex, adult, donor10258	10373-105G4	38.90	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	53.61	6.58	0.00
parietal lobe, adult, donor10252	10157-103A4	67.55	4.56	0.00
parietal lobe, adult, pool1	10034-101E7	74.55	4.05	1.06
parietal lobe, fetal, donor1	10072-101I9	48.49	4.85	0.00
parietal lobe, newborn, donor10223	10356-105E5	48.23	4.49	2.99
parotid gland, adult	10199-103F1	146.77	8.02	4.32
penis, adult	10200-103F2	54.25	3.76	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	60.06	3.35	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	89.02	6.99	4.81
pineal gland - adult, donor10196	10179-103C8	39.99	3.23	3.23
pineal gland, adult, donor10252	10160-103A7	131.47	14.21	2.96
pineal gland, adult, donor10258	10377-105G8	43.27	4.39	3.14
pituitary gland - adult, donor10196	10180-103C9	237.77	16.19	11.13
pituitary gland, adult, donor10252	10162-103A9	354.40	27.10	11.47
pituitary gland, adult, donor10258	10378-105G9	80.02	3.40	2.55
placenta, adult, pool1	10021-101D3	119.11	7.42	2.90
plasma cell leukemia cell line:ARH-77	10840-111E3	103.29	5.83	1.85
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	187.86	16.65	2.49
pons, adult, pool1	10033-101E6	75.48	7.75	2.24
postcentral gyrus, adult, pool1	10032-101E5	63.29	4.53	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	66.10	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	122.94	7.72	4.22
prostate cancer cell line:PC-3	10439-106E7	87.30	7.44	2.18
prostate, adult, pool1	10022-101D4	73.10	3.26	1.54
putamen, adult, donor10196	10176-103C5	79.79	3.30	0.94
putamen, adult, donor10252	10152-102I8	47.06	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	48.08	0.00	5.46
putamen, adult, donor10258, tech_rep2	10372-105G3	44.46	2.17	0.72
putamen, newborn, donor10223	10365-105F5	118.45	4.50	3.00
rectal cancer cell line:TT1TKB	10469-106I1	85.83	3.49	2.04
rectum, fetal, donor1	10067-101I4	45.90	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	197.16	12.72	3.60
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	159.47	9.11	4.14
retina, adult, pool1	10030-101E3	65.60	4.87	0.50
retinoblastoma cell line:Y79	10475-106I7	83.14	7.79	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	49.92	3.32	1.35
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	95.89	7.31	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	43.20	2.27	0.76
salivary acinar cells, donor1	11771-123I7	62.31	3.40	1.78
salivary acinar cells, donor2	11772-123I8	61.00	3.30	1.38
salivary acinar cells, donor3	11773-123I9	19.20	0.66	0.00
salivary gland, adult, pool1	10093-102C3	119.54	6.86	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	75.04	7.17	2.61
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	74.53	5.88	3.06
seminal vesicle, adult	10201-103F3	69.31	2.65	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	119.52	8.02	6.80
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	64.42	4.53	3.27
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	98.35	9.03	7.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	101.14	5.37	3.09
signet ring carcinoma cell line:Kato III	10436-106E4	100.14	10.17	3.76
signet ring carcinoma cell line:NUGC-4	10483-107A6	103.61	5.94	3.10
skeletal muscle - soleus muscle, donor1	10282-104F3	9.22	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	24.47	1.80	0.00
skeletal muscle, fetal, donor1	10066-101I3	29.15	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	6.79	0.00
skin, fetal, donor1	10065-101I2	71.33	3.79	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	62.37	7.00	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	66.51	10.09	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	101.77	5.01	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	78.13	7.42	2.14
small cell lung carcinoma cell line:NCI-H82	10842-111E5	184.49	13.67	7.56
small cell lung carcinoma cell line:WA-hT	10562-108A4	78.45	5.67	2.62
small intestine, adult, pool1	10024-101D6	115.26	6.81	3.82
small intestine, fetal, donor1	10064-101I1	73.71	5.90	2.95
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	106.17	5.13	4.62
smooth muscle, adult, pool1	10048-101G3	47.30	2.33	0.26
somatostatinoma cell line:QGP-1	10781-110G7	53.07	3.22	1.88
spinal cord - adult, donor10196	10181-103D1	44.50	2.29	0.46
spinal cord, adult, donor10252	10159-103A6	71.76	9.07	0.39
spinal cord, adult, donor10258	10369-105F9	48.43	4.15	0.69
spinal cord, fetal, donor1	10056-101H2	65.86	4.88	2.44
spinal cord, newborn, donor10223	10359-105E8	89.55	4.59	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	53.02	6.57	3.14
spleen, adult, pool1	10025-101D7	73.79	5.40	2.20
spleen, fetal, pool1	10044-101F8	53.16	4.29	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	90.68	5.69	2.28
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	116.39	8.92	3.23
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	73.73	5.59	3.15
squamous cell carcinoma cell line:T3M-5	10616-108G4	73.89	6.65	5.08
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	165.24	11.82	8.67
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	60.58	2.97	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	52.46	2.96	1.27
stomach, fetal, donor1	10062-101H8	37.38	3.20	0.00
submaxillary gland, adult	10202-103F4	107.67	8.55	1.71
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	82.87	4.78	0.62
substantia nigra, adult, donor10258	10371-105G2	35.69	5.17	1.03
substantia nigra, newborn, donor10223	10358-105E7	43.81	2.12	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	96.98	8.02	2.06
temporal lobe, adult, pool1	10031-101E4	36.37	2.80	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	33.48	6.41	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	43.51	3.08	1.32
tenocyte, donor1	11763-123H8	119.04	9.43	4.54
tenocyte, donor2	11765-123I1	63.33	3.82	1.53
tenocyte, donor3	11768-123I4	117.13	5.93	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	63.74	9.01	6.80
teratocarcinoma cell line:NCR-G1	10798-110I6	63.66	5.40	2.31
teratocarcinoma cell line:PA-1	10807-111A6	60.60	7.90	4.18
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	93.43	6.22	5.97
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	83.58	7.94	5.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	54.09	5.56	1.85
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	105.53	6.19	4.23
testis, adult, pool1	10026-101D8	83.75	6.01	4.40
testis, adult, pool2	10096-102C6	52.33	3.61	1.80
thalamus - adult, donor10196	10168-103B6	50.78	0.00	1.10
thalamus, adult, donor10252	10154-103A1	88.30	3.75	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.60	0.82	0.66
thalamus, newborn, donor10223	10366-105F6	52.93	2.30	1.73
throat, adult	10209-103G2	71.90	3.50	1.75
throat, fetal, donor1	10061-101H7	53.02	4.27	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	68.76	4.77	0.99
thymus, adult, pool1	10027-101D9	92.75	3.18	0.40
thymus, fetal, pool1	10043-101F7	98.50	4.78	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	74.59	5.45	4.39
thyroid carcinoma cell line:TCO-1	10783-110G9	83.12	5.45	2.37
thyroid, adult, pool1	10028-101E1	117.48	5.23	1.40
thyroid, fetal, donor1	10060-101H6	60.64	4.22	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	0.00	0.00
tongue, adult	10203-103F5	59.77	3.95	1.63
tongue, fetal, donor1	10059-101H5	58.33	2.76	0.39
tonsil, adult, pool1	10047-101G2	95.97	5.61	1.40
trachea, adult, pool1	10029-101E2	105.68	7.44	2.86
trachea, fetal, donor1	10058-101H4	97.33	3.08	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	94.95	8.50	3.54
transitional-cell carcinoma cell line:5637	10418-106C4	81.46	6.48	3.75
transitional-cell carcinoma cell line:JMSU1	10492-107B6	107.02	6.58	2.35
tridermal teratoma cell line:HGRT	10694-109G1	32.34	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	62.05	3.72	1.86
umbilical cord, fetal, donor1	10057-101H3	43.82	0.00	2.09
uterus, adult, pool1	10100-102D1	80.20	6.65	1.54
uterus, fetal, donor1	10055-101H1	94.19	2.56	2.56
vagina, adult	10204-103F6	44.59	3.88	0.00
vein, adult	10191-103E2	42.96	3.51	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	53.67	3.20	0.53